"Biogen Inc. rose the most since November after it received approval for its controversial Alzheimer’s disease therapy. Competitors including Eli Lilly & Co. and AC Immune SA also rallied, helping push the Nasdaq Biotech Index toward the highest since late April." (Bloomberg, 6/6/21).
Will we see NAS push to April's high or will it reject off of 13830? I feel as though a 200 point movement to the upside is too much to ask for with the concerns over inflation still heavy above our heads.
Big move likely to happen during Asian but i'll be asleep. Ha.
Zones and channels marked out to the downside ready to buy from if it does end up crashing though.